We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
+$154M
Cap. Flow
+$200M
Cap. Flow %
9.8%
Top 10 Hldgs %
45.8%
Holding
42
New
2
Increased
10
Reduced
26
Closed
1

Top Buys

Rank Stock Value
1
QXO
QXO Inc
QXO
+$226M
2
PLAY icon
Dave & Buster's
PLAY
+$44.3M
3
RPRX icon
Royalty Pharma
RPRX
+$17.1M
4
SOFI icon
SoFi Technologies
SOFI
+$14.2M
5
SDRL icon
Seadrill
SDRL
+$5.43M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$26.7M
2
EVRI
Everi Holdings
EVRI
+$13M
3
WAL icon
Western Alliance Bancorporation
WAL
+$11.5M
4
FISV
Fiserv Inc
FISV
+$9.7M
5
EXPE icon
Expedia Group
EXPE
+$9.09M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.99%
2 Financials 16.16%
3 Communication Services 15.58%
4 Industrials 11.96%
5 Healthcare 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QXO
1
QXO Inc
QXO
$17.1B
$122M 5.99%
+7,741,847
New +$226M
AMZN icon
2
Amazon
AMZN
$3T
$117M 5.72%
625,328
-6,369
-1% -$1.16M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$98.8M 4.85%
595,736
-5,542
-0.9% -$930K
C icon
4
Citigroup
C
$226B
$96.5M 4.74%
1,541,858
-121,252
-7% -$7.5M
EXPE icon
5
Expedia Group
EXPE
$37.3B
$95.8M 4.7%
647,329
-68,646
-10% -$9.09M
PPLI
6
People Inc
PPLI
$3.2B
$89.5M 4.4%
2,027,848
+80,533
+4% +$3.35M
ET icon
7
Energy Transfer Partners
ET
$70B
$85M 4.17%
5,296,830
-63,827
-1% -$1.03M
META icon
8
Meta Platforms (Facebook)
META
$1.52T
$84.6M 4.15%
147,824
-12,101
-8% -$6.23M
NVDA icon
9
NVIDIA
NVDA
$5.43T
$73.9M 3.63%
608,728
+2,889
+0.5% +$341K
BABA icon
10
Alibaba
BABA
$307B
$69.9M 3.43%
658,726
-67,800
-9% -$5.55M
GM icon
11
General Motors
GM
$76.8B
$69.5M 3.41%
1,550,074
-88,939
-5% -$4.12M
OMF icon
12
OneMain Financial
OMF
$7.43B
$66.5M 3.27%
1,413,215
-140,895
-9% -$6.77M
DAL icon
13
Delta Air Lines
DAL
$60.1B
$64.2M 3.15%
1,263,574
-77,929
-6% -$3.4M
UBS icon
14
UBS Group
UBS
$176B
$62.5M 3.07%
2,022,019
-6,918
-0.3% -$208K
RPRX icon
15
Royalty Pharma
RPRX
$25.3B
$57.7M 2.84%
2,041,195
+616,805
+43% +$17.1M
NCLH icon
16
Norwegian Cruise Line
NCLH
$8.83B
$57.5M 2.82%
2,801,950
-35,058
-1% -$637K
UAL icon
17
United Airlines
UAL
$41.7B
$57.4M 2.82%
1,005,557
+12,075
+1% +$559K
CROX icon
18
Crocs
CROX
$6.59B
$55.2M 2.71%
380,969
+1,460
+0.4% +$199K
ILMN icon
19
Illumina
ILMN
$29B
$53.7M 2.64%
411,555
-3,303
-0.8% -$407K
BIIB icon
20
Biogen
BIIB
$30.2B
$49.6M 2.44%
255,942
-1,327
-0.5% -$278K
CVS icon
21
CVS Health
CVS
$122B
$48.4M 2.37%
769,096
+29,387
+4% +$1.71M
MAT icon
22
Mattel
MAT
$4.2B
$48.3M 2.37%
2,536,645
-29,426
-1% -$542K
GOOS
23
Canada Goose Holdings
GOOS
$862M
$46.7M 2.29%
3,726,387
-157,948
-4% -$1.79M
SOFI icon
24
SoFi Technologies
SOFI
$23.5B
$45.6M 2.24%
5,795,687
+1,950,649
+51% +$14.2M
PLAY icon
25
Dave & Buster's
PLAY
$364M
$44.3M 2.17%
+1,300,598
New +$44.3M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Patient Capital Management held 42 positions worth $2.04B, up 8.2% from $1.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Patient Capital Management deployed $200M of net new capital in Q3 2024, opening 2 new positions and adding to 10 existing holdings. Its largest new stake was QXO Inc: 7,741,847 shares worth $122M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 33% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $26.7M trimmed.

  • Patient Capital Management's largest Q3 2024 buy was QXO Inc: 7,741,847 shares worth $122M.
  • Patient Capital Management added most to Royalty Pharma in Q3 2024, an estimated $17.1M increase.
  • Patient Capital Management's biggest Q3 2024 reduction was JPMorgan Chase, cutting an estimated $26.7M.
  • Patient Capital Management fully exited Uber in Q3 2024, selling an estimated $1.9M.
  • Patient Capital Management's ten largest holdings make up 46% of its $2.04B portfolio in Q3 2024.
  • Patient Capital Management opened 2 new positions and closed 1 in Q3 2024.
  • Patient Capital Management's portfolio value rose 8.2% quarter-over-quarter to $2.04B.

Based on Patient Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.